Packaging Dynamics - When-Issued Common Stock (MM) (PKDY) Quote

This is OTC. If you do not like giant share structures, toxic debt and dilution, you should not be here. If a high AS and toxic debt bother you, you have 9,999 other OTC tickers to bash!

$NCPL next 500% play gers it going !! Orions members rocking it this week

True and I was just stating facts nothing more.

Good morning everyone!! Have a wonderful Friday !!

$NCPL next 500% play gers it going !! Orions members rocking it this week

My opinion - there is no delay...

Just smoke and mirrors distortion of reality in a corrupt market.

My only post for today on this heavily censored platform.

How big will MAX Clean 756 be?? The potential here is HUGE.
I have worked in the HVAC industry for many years. This system is compatible with Rheem, Lennox and Carrier HVAC systems. These are the 3 biggest players in the game. A retrofit solution to work with these systems targets almost 100%

You left out the help they had from the master of the front loaded pumps, Mr. Eloquent himself, Sterling the scam artist

Chuckface has been exposed as a complete fraud and notice the ones that were a part of it, that pretended to worship the statues they created in his likeness, al

I believe it is an excellent collaboration. Looking at the safety profiles of DCVax-L, Walgreens are so eager to collaborate. Walgreens can help the logistics and distribution. They have the locations. They recently have the Primary Care Physician via VillageMD. These Primary Care can be trained to

I think everybody in the data transmission industry and all internet companies are looking to lower their operating costs and improve their bottom line. Power is a major cost factor. Moreover they need to do that and at the same time offer more speed to their customers. That seems a ‘ no brainer’.

BITCOIN 🌪️🌪️🌪️🌪️🌪️🌪️🌪️ 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

Nope. No evidence...

https://investorshub.advfn.com/uimage/uploads/2023/12/16/hvnjkKBLB_SILK.jpeg

“I am proud of the work accomplished and very impressed by the performance of the BAM-1 silkworm lines,” Dr. Nirmal Kumar, stated. “The luster of the BAM-1 silk is very uni

Here we are, the end of another week of absolutely nothing from this ticker.
Yield sign still up. Still waiting for the multiple filings this ticker is required to reveal, but has failed to produce.
Maybe today before the long weekend. But, don't hold your breath. For this ticker...it

Good news, always good to have the support of a big Wallstreet Bank. I assume this ‘ engagement’ will lead to a positive EXIM outcome and than finally we are “ off to the races”. ‘Chinese hacking’ efforts can now be neutralised.

At this time there is no relationship between NWBO and Walgreens. I don't think there would be ever. There are more high priority agenda in front of NWBO like partnerships, combo trials and more importantly how to proceed with DCVax- L and D.

I think there would be a big announcement

Bio9999’s excellent write up gave a prelude what this collaboration could transpire.

https://www.reddit.com/r/NWBO/s/5DjXvhYnpB

I was promised some abstracts...

they are movin this bad boy -----when they start selling again a short will pay big time--unless they get bt out and the scammers are thrown out---tmonkey

Gonna end the week strong?

Reasonable volume this week, some interest in the possibilities it does appear

8's and 9's being accumulated @ SAPX, .001 break could lead to a decent push upward...

While 12 to 1 Sells vs Buys sucks,

at least there were Buyers stopping a complete meltdown and bloodbath. Profit-taking is the name of the game.

Good morning CLNVERS

100% agree Doc logic.

GLTU

Walgreens’ annual revenues are currently plateaued at about $135 Billions. So having expected $24 Billions additional revenues annually from Cell and Gene therapies lines certainly give Walgreens quite a big boost.

https://www.macrotrends.net/stocks/charts/WBA/walgreens/revenue

"catalyst" three abstracts on mRNA-4157 (V940), an investigational mRNA individualized neoantigen therapy, have been accepted for presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 31 - June 4 in Chicago, IL. mRNA-4157 (V940) is being joint